Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline
Authors:
- Frank T. LeoneFLFrank T. Leone
- Yuqing ZhangYZYuqing Zhang
- Sarah Evers-CaseySESarah Evers-Casey
- A. Eden EvinsAEA. Eden Evins
- Michelle N. EakinMEMichelle N. Eakin
- Joelle FathiJFJoelle Fathi
- Kathleen FennigKFKathleen Fennig
- Patricia FolanPFPatricia Folan
- Panagis GaliatsatosPGPanagis Galiatsatos
- Hyma GogineniHGHyma Gogineni
- Stephen KantrowSKStephen Kantrow
- Hasmeena KathuriaHKHasmeena Kathuria
Top Cited Papers
Open Access
- 1 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (2) , e5-e31
Abstract
Background: Current tobacco treatment guidelines have established the efficacy of available interventions, but they do not provide detailed guidance for common implementation questions frequently faced in the clinic. An evidence-based guideline was created that addresses several pharmacotherapy-initiation questions that routinely confront treatment teams. Methods: Individuals with diverse expertise related to smoking cessation were empaneled to prioritize questions and outcomes important to clinicians. An evidence-synthesis team conducted systematic reviews, which informed recommendations to answer the questions. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach was used to rate the certainty in the estimated effects and the strength of recommendations. Results: The guideline panel formulated five strong recommendations and two conditional recommendations regarding pharmacotherapy choices. Strong recommendations include using varenicline rather than a nicotine patch, using varenicline rather than bupropion, using varenicline rather than a nicotine patch in adults with a comorbid psychiatric condition, initiating varenicline in adults even if they are unready to quit, and using controller therapy for an extended treatment duration greater than 12 weeks. Conditional recommendations include combining a nicotine patch with varenicline rather than using varenicline alone and using varenicline rather than electronic cigarettes. Conclusions: Seven recommendations are provided, which represent simple practice changes that are likely to increase the effectiveness of tobacco-dependence pharmacotherapy.Keywords
This publication has 157 references indexed in Scilit:
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trialBMC Medicine, 2013
- Developing a Rational Approach to Tobacco Use Treatment in Pulmonary PracticeClinical Pulmonary Medicine, 2012
- A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit DatesNicotine & Tobacco Research, 2011
- Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot TrialNicotine & Tobacco Research, 2011
- Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled TrialNicotine & Tobacco Research, 2011
- Counselors’ Knowledge of the Adoption of Tobacco Cessation Medications in Substance Abuse Treatment ProgramsThe American Journal on Addictions, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United StatesJournal of Substance Abuse Treatment, 2008
- Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale.Psychology of Addictive Behaviors, 2007